Related Experiment Video
Updated: Jan 14, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
[Polyarteritis nodosa]
Étienne Ghrenassia1, Alexis Guedon1, Jérôme Hadjadj1
1Sorbonne Université, service de médecine interne, AP-HP, hôpital Saint-Antoine, Paris, France.
Abstract:
POLYARTERITIS NODOSA. Polyarteritis nodosa are systemic necrotizing vasculitis of medium size vessels. They are complicated by stenosis or aneurysms of median size vessels. Clinical manifestations are fever, weight loss, mononeuropathy, myalgias, arthritis, cutaneous lesions. Vital and functional prognosis are conditioned by the presence of digestive tract (perforations, bleeding), renal (severe hypertension, vascular nephropathy), cardiac, and central nervous system involvement. Periarteritis nodosa may be primitive or secondary to hemopathy, solid neoplasms, viral infections (B hepatitis, C hepatitis, HIV), autoinflammatory syndrome as ADA2 deficiency. Treatment needs steroids, and severe forms need association with cyclophosphamide.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Peripheral Artery Disease I: Introduction
Nephrotic Syndrome I : Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Endocarditis II: Clinical Features of Infective Endocarditis
Pericarditis I: Introduction

